News

Filter

Current filters:

None

8030 to 8039 of 97551 results

Gilead's Stribild, formerly "Quad," gets FDA nod

29-08-2012

The US Food and Drug Administration has approved US biotech firm Gilead Sciences' (Nasdaq: GILD) Stribild…

Anti-viralsBiotechnologyGilead SciencesNorth AmericaQuadRegulationStribild

First myelofibrosis drug, Novartis' Jakavi, approved in Europe

29-08-2012

Swiss drug major Novartis (NOVN: VX) received approval yesterday from the European Commission for Jakavi…

EuropeIncyteJakafiJakaviNovartisOncologyPharmaceuticalRare diseasesRegulation

Meda's Zyclara approved in the EU

29-08-2012

Sweden-based Meda (OMX: MEDA A) yesterday announced that the European Commission has granted marketing…

DermatologicalsEuropeMedaOncologyPharmaceuticalRegulationZyclara

GSK completes LAMA/LABA Ph III program; readies for global filings

28-08-2012

UK pharma giant GlaxoSmithKline (LSE: GSK) and US partner Theravance (Nasdaq: THRX) say they have completed…

GlaxoSmithKlinePharmaceuticalRegulationResearchRespiratory and PulmonaryTheravanceumeclidiniumvilanterol

Ipsen posts 8% rise in first-half 2012 sales

28-08-2012

French drugmaker Ipsen (Euronext: IPN) yesterday reported first-half 2012 financial results with 8% growth…

FinancialIpsenPharmaceutical

8030 to 8039 of 97551 results

COMPANY SPOTLIGHT

Parexel

Parexel

Back to top